Accession Number: | 0001567619-20-013438 |
Date: | 2020-07-14 |
Issuer: | ANGIODYNAMICS INC (ANGO) |
Original Submission Date: |
CLEMMER JAMES C
14 PLAZA DRIVE
LATHAM, NY 12110
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-07-14 | A | 54,435 | a | $0.00 | 310,608 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
PERFORMANCE RIGHT | 0.0 | 2020-07-14 | deemed execution date | A | 108,871 (a) | common stock 108,871 | $0.00 | 108,871 | direct | |||
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 9.92 | 2020-07-14 | deemed execution date | A | 160,237 (a) | 2021-07-14 | 2030-07-14 | common stock 160,237 | $9.92 | 160,237 | direct |
ID | footnote |
---|---|
f1 | this acquisition of 54,435 shares of common stock ("common stock") of angiodynamics, inc. represents 54,435 restricted stock units, each of which represents a contingent right to receive one share of common stock. these restricted stock units vest in four equal annual installments beginning on july 14, 2021, such that 25% of the restricted stock units will vest on each of july 14, 2021, 2022, 2023 and 2024. |
f2 | each performance right represents a contingent right to receive one share of common stock. the target number of shares of common stock is set forth in columns 5 and 7 of table ii. between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. any shares that do not vest at the end of the performance period will be forfeited. |
f3 | these stock options vest in four equal annual installments beginning on july 14, 2021, such that 25% of the options will vest on each of july 14, 2021, 2022, 2023 and 2024. |